Nearly 90% of U.S. gastroenterologists are open to using AI for help performing high quality colonoscopies. And of these, 85% believe that computer-assisted polyp detection (CADe) stands to improve their endoscopic performance.
On the heels of receiving the first New Technology Add-on Payment from CMS for an AI powered software system, this award further validates the real world benefits Viz.ai brings to stroke patients.